{
  "nctId": "NCT06835985",
  "briefTitle": "Social Media Intervention for Online Victimized Youth",
  "officialTitle": "sIRB: Social Media Intervention for Online Victimized Youth",
  "protocolDocument": {
    "nctId": "NCT06835985",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2025-01-27",
    "uploadDate": "2025-01-29T10:41",
    "size": 177854,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT06835985/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 75,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2025-05-06",
    "completionDate": "2027-07-31",
    "primaryCompletionDate": "2026-02-28",
    "firstSubmitDate": "2025-02-14",
    "firstPostDate": "2025-02-19"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Adolescents age 12-18\n* Current moderate to severe depression (PHQ-9-M ≥ 11)\n* Patients must screen positive for depression, PHQ-9-M score ≥ 11, and online victimization (OV). A positive screen will be OV that occurred \"a few times\" for at least one type of OV or \"once\" for at least two types of OV.\n\nExclusion Criteria:\n\n* Conditions that might impair their ability to effectively deploy interventions, including current manic or psychotic episode, presence of a life-threatening medical condition requiring immediate treatment, intellectual or developmental disability precluding comprehension of study procedure\n* Referring providers will be advised that adolescents must be capable of safely participating, specifically that they do not need urgent medical or psychiatric treatment.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "12 Years",
    "maximumAge": "18 Years",
    "stdAges": [
      "CHILD",
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Engagement with the chatbot",
        "description": "Engagement will be measured by the timestamps of usage of the intervention. Timestamps will be generated when there is a message from the user and a corresponding message from the chatbot.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Engagement with the chatbot",
        "description": "Engagement will be measured by the timestamps of usage of the intervention. Timestamps will be generated when there is a message from the user and a corresponding message from the chatbot.",
        "timeFrame": "1 month"
      },
      {
        "measure": "Engagement with the chatbot",
        "description": "Engagement will be measured by the timestamps of usage of the intervention. Timestamps will be generated when there is a message from the user and a corresponding message from the chatbot.",
        "timeFrame": "3 months"
      },
      {
        "measure": "Engagement with the chatbot",
        "description": "Engagement will be measured by the timestamps of usage of the intervention. Timestamps will be generated when there is a message from the user and a corresponding message from the chatbot.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Engagement with the chatbot",
        "description": "Engagement will be measured by the timestamps of usage of the intervention. Timestamps will be generated when there is a message from the user and a corresponding message from the chatbot.",
        "timeFrame": "12 months"
      },
      {
        "measure": "Perceived satisfaction of the chatbot",
        "description": "Perceived satisfaction of the chatbot will be measured by the Post-Study System Usability Questionnaire (PSSUQ). Response options and scores include: \"Strongly Agree (1)\" to \"Strongly Disagree (7).\" Scores range from 1 to 7, with higher scores indicating lower levels of satisfaction and lower scores indicating higher levels satisfaction.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Perceived satisfaction of the chatbot",
        "description": "Perceived satisfaction of the chatbot will be measured by the Post-Study System Usability Questionnaire (PSSUQ). Response options and scores include: \"Strongly Agree (1)\" to \"Strongly Disagree (7).\" Scores range from 1 to 7, with higher scores indicating lower levels of satisfaction and lower scores indicating higher levels satisfaction.",
        "timeFrame": "1 month"
      },
      {
        "measure": "Perceived satisfaction of the chatbot",
        "description": "Perceived satisfaction of the chatbot will be measured by the Post-Study System Usability Questionnaire (PSSUQ). Response options and scores include: \"Strongly Agree (1)\" to \"Strongly Disagree (7).\" Scores range from 1 to 7, with higher scores indicating lower levels of satisfaction and lower scores indicating higher levels satisfaction.",
        "timeFrame": "3 months"
      },
      {
        "measure": "Perceived satisfaction of the chatbot",
        "description": "Perceived satisfaction of the chatbot will be measured by the Post-Study System Usability Questionnaire (PSSUQ). Response options and scores include: \"Strongly Agree (1)\" to \"Strongly Disagree (7).\" Scores range from 1 to 7, with higher scores indicating lower levels of satisfaction and lower scores indicating higher levels satisfaction.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Perceived satisfaction of the chatbot",
        "description": "Perceived satisfaction of the chatbot will be measured by the Post-Study System Usability Questionnaire (PSSUQ). Response options and scores include: \"Strongly Agree (1)\" to \"Strongly Disagree (7).\" Scores range from 1 to 7, with higher scores indicating lower levels of satisfaction and lower scores indicating higher levels satisfaction.",
        "timeFrame": "12 months"
      }
    ],
    "secondary": [
      {
        "measure": "Levels of general self-efficacy",
        "description": "Levels of general self-efficacy will be measured by the General Self-Efficacy Scale (GSE). Response options and scores include: \"Not at all true (1),\" \"Hardly true (2),\" \"Moderately true,\" and \"Exactly true (4).\" Scores range from 10 to 40, with higher scores indicating higher levels of self-efficacy and lower scores indicating lower levels of self-efficacy.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Levels of general self-efficacy",
        "description": "Levels of general self-efficacy will be measured by the General Self-Efficacy Scale (GSE). Response options and scores include: \"Not at all true (1),\" \"Hardly true (2),\" \"Moderately true,\" and \"Exactly true (4).\" Scores range from 10 to 40, with higher scores indicating higher levels of self-efficacy and lower scores indicating lower levels of self-efficacy.",
        "timeFrame": "1 month"
      },
      {
        "measure": "Levels of general self-efficacy",
        "description": "Levels of general self-efficacy will be measured by the General Self-Efficacy Scale (GSE). Response options and scores include: \"Not at all true (1),\" \"Hardly true (2),\" \"Moderately true,\" and \"Exactly true (4).\" Scores range from 10 to 40, with higher scores indicating higher levels of self-efficacy and lower scores indicating lower levels of self-efficacy.",
        "timeFrame": "3 months"
      },
      {
        "measure": "Levels of general self-efficacy",
        "description": "Levels of general self-efficacy will be measured by the General Self-Efficacy Scale (GSE). Response options and scores include: \"Not at all true (1),\" \"Hardly true (2),\" \"Moderately true,\" and \"Exactly true (4).\" Scores range from 10 to 40, with higher scores indicating higher levels of self-efficacy and lower scores indicating lower levels of self-efficacy.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Levels of general self-efficacy",
        "description": "Levels of general self-efficacy will be measured by the General Self-Efficacy Scale (GSE). Response options and scores include: \"Not at all true (1),\" \"Hardly true (2),\" \"Moderately true,\" and \"Exactly true (4).\" Scores range from 10 to 40, with higher scores indicating higher levels of self-efficacy and lower scores indicating lower levels of self-efficacy.",
        "timeFrame": "12 months"
      },
      {
        "measure": "Levels of distress tolerance",
        "description": "Levels of distress tolerance will be measured by the Distress Tolerance Scale (DTS). Response options and scores include: \"Strongly Disagree (1),\" \"Mildly Disagree (2),\" \"Agree and Disagree Equally (3),\" \"Mildly Agree (4),\" and \"Strongly Agree (5).\" Scores range from 1 to 5, with higher scores indicating higher levels of distress tolerance and lower scores indicating lower levels of distress tolerance.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Levels of distress tolerance",
        "description": "Levels of distress tolerance will be measured by the Distress Tolerance Scale (DTS). Response options and scores include: \"Strongly Disagree (1),\" \"Mildly Disagree (2),\" \"Agree and Disagree Equally (3),\" \"Mildly Agree (4),\" and \"Strongly Agree (5).\" Scores range from 1 to 5, with higher scores indicating higher levels of distress tolerance and lower scores indicating lower levels of distress tolerance.",
        "timeFrame": "1 month"
      },
      {
        "measure": "Levels of distress tolerance",
        "description": "Levels of distress tolerance will be measured by the Distress Tolerance Scale (DTS). Response options and scores include: \"Strongly Disagree (1),\" \"Mildly Disagree (2),\" \"Agree and Disagree Equally (3),\" \"Mildly Agree (4),\" and \"Strongly Agree (5).\" Scores range from 1 to 5, with higher scores indicating higher levels of distress tolerance and lower scores indicating lower levels of distress tolerance.",
        "timeFrame": "3 months"
      },
      {
        "measure": "Levels of distress tolerance",
        "description": "Levels of distress tolerance will be measured by the Distress Tolerance Scale (DTS). Response options and scores include: \"Strongly Disagree (1),\" \"Mildly Disagree (2),\" \"Agree and Disagree Equally (3),\" \"Mildly Agree (4),\" and \"Strongly Agree (5).\" Scores range from 1 to 5, with higher scores indicating higher levels of distress tolerance and lower scores indicating lower levels of distress tolerance.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Levels of distress tolerance",
        "description": "Levels of distress tolerance will be measured by the Distress Tolerance Scale (DTS). Response options and scores include: \"Strongly Disagree (1),\" \"Mildly Disagree (2),\" \"Agree and Disagree Equally (3),\" \"Mildly Agree (4),\" and \"Strongly Agree (5).\" Scores range from 1 to 5, with higher scores indicating higher levels of distress tolerance and lower scores indicating lower levels of distress tolerance.",
        "timeFrame": "12 months"
      }
    ],
    "other": [
      {
        "measure": "Severity of depression",
        "description": "Severity of depression will be measured by the Patient Health Questionnaire-9: Modified for Teens (PHQ-9 M). Response options and scores include: \"Not at all (0),\" \"Several days (1),\" \"More than half the days (2),\" and \"Nearly every day (3).\" Scores range from 0 to 27, with higher scores indicating higher levels of depression severity and lower scores indicating lower levels of depression severity.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Severity of depression",
        "description": "Severity of depression will be measured by the Patient Health Questionnaire-9: Modified for Teens (PHQ-9 M). Response options and scores include: \"Not at all (0),\" \"Several days (1),\" \"More than half the days (2),\" and \"Nearly every day (3).\" Scores range from 0 to 27, with higher scores indicating higher levels of depression severity and lower scores indicating lower levels of depression severity.",
        "timeFrame": "1 month"
      },
      {
        "measure": "Severity of depression",
        "description": "Severity of depression will be measured by the Patient Health Questionnaire-9: Modified for Teens (PHQ-9 M). Response options and scores include: \"Not at all (0),\" \"Several days (1),\" \"More than half the days (2),\" and \"Nearly every day (3).\" Scores range from 0 to 27, with higher scores indicating higher levels of depression severity and lower scores indicating lower levels of depression severity.",
        "timeFrame": "3 months"
      },
      {
        "measure": "Severity of depression",
        "description": "Severity of depression will be measured by the Patient Health Questionnaire-9: Modified for Teens (PHQ-9 M). Response options and scores include: \"Not at all (0),\" \"Several days (1),\" \"More than half the days (2),\" and \"Nearly every day (3).\" Scores range from 0 to 27, with higher scores indicating higher levels of depression severity and lower scores indicating lower levels of depression severity.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Severity of depression",
        "description": "Severity of depression will be measured by the Patient Health Questionnaire-9: Modified for Teens (PHQ-9 M). Response options and scores include: \"Not at all (0),\" \"Several days (1),\" \"More than half the days (2),\" and \"Nearly every day (3).\" Scores range from 0 to 27, with higher scores indicating higher levels of depression severity and lower scores indicating lower levels of depression severity.",
        "timeFrame": "12 months"
      },
      {
        "measure": "Severity of suicidal ideation and behavior",
        "description": "Severity of suicidal ideation and behavior will be measured with the Columbia Suicide Severity Rating Scale (C-SSRS), an interviewer-rated measure. Presence of suicidal ideation and behavior will be indicated with yes/no response options. Intensity of ideation will be rated on a scale from 1-5 with higher numbers reflecting higher levels of intensity and lower numbers reflecting lower levels of intensity.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Severity of suicidal ideation and behavior",
        "description": "Severity of suicidal ideation and behavior will be measured with the Columbia Suicide Severity Rating Scale (C-SSRS), an interviewer-rated measure. Presence of suicidal ideation and behavior will be indicated with yes/no response options. Intensity of ideation will be rated on a scale from 1-5 with higher numbers reflecting higher levels of intensity and lower numbers reflecting lower levels of intensity.",
        "timeFrame": "1 month"
      },
      {
        "measure": "Severity of suicidal ideation and behavior",
        "description": "Severity of suicidal ideation and behavior will be measured with the Columbia Suicide Severity Rating Scale (C-SSRS), an interviewer-rated measure. Presence of suicidal ideation and behavior will be indicated with yes/no response options. Intensity of ideation will be rated on a scale from 1-5 with higher numbers reflecting higher levels of intensity and lower numbers reflecting lower levels of intensity.",
        "timeFrame": "3 months"
      },
      {
        "measure": "Severity of suicidal ideation and behavior",
        "description": "Severity of suicidal ideation and behavior will be measured with the Columbia Suicide Severity Rating Scale (C-SSRS), an interviewer-rated measure. Presence of suicidal ideation and behavior will be indicated with yes/no response options. Intensity of ideation will be rated on a scale from 1-5 with higher numbers reflecting higher levels of intensity and lower numbers reflecting lower levels of intensity.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Severity of suicidal ideation and behavior",
        "description": "Severity of suicidal ideation and behavior will be measured with the Columbia Suicide Severity Rating Scale (C-SSRS), an interviewer-rated measure. Presence of suicidal ideation and behavior will be indicated with yes/no response options. Intensity of ideation will be rated on a scale from 1-5 with higher numbers reflecting higher levels of intensity and lower numbers reflecting lower levels of intensity.",
        "timeFrame": "12 months"
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 10,
      "secondaryCount": 10,
      "otherCount": 10,
      "totalCount": 30
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-21T22:34:03.590Z",
  "dataSource": "ClinicalTrials.gov API v2 - Mass Collection"
}